A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
NCT01550965
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
463
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
BIOLOGICAL:
Adalimumab
Sponsor
AbbVie (prior sponsor, Abbott)